Comparison between Ganga Pharmaceuticals IPO and K.P.Energy IPO.
Ganga Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while K.P.Energy IPO is a SME Bookbuilding proposed to list at BSE SME.
| Ganga Pharmaceuticals IPO | K.P.Energy IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | First Overseas Capital Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Alacrity Securities Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.54 Cr whereas the issue size of the K.P.Energy IPO is up to ₹6.10 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of K.P.Energy IPO is ₹70.00 per share.
| Ganga Pharmaceuticals IPO | K.P.Energy IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹60.00 per share | |
| Issue Price (Upper) | ₹70.00 per share | |
| Issue Price (Final) | ₹15.00 per share | ₹70.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 8000 shares | 2000 shares |
| Fresh Issue Size | 10,24,000 shares | 8,72,000 shares |
| Fresh Issue Size (Amount) | up to ₹1.54 Cr | up to ₹6.10 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 10,24,000 shares | 8,72,000 shares |
| Issue Size Total (Amount) | up to ₹1.54 Cr | up to ₹6.10 Cr |
Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while K.P.Energy IPO opens on Feb 15, 2016. The closing date of Ganga Pharmaceuticals IPO and K.P.Energy IPO is Feb 09, 2016, and Feb 17, 2016, respectively.
| Ganga Pharmaceuticals IPO | K.P.Energy IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2016 | Feb 15, 2016 |
| Issue Close | Feb 09, 2016 | Feb 17, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Feb 22, 2016 | Feb 25, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Ganga Pharmaceuticals IPO P/E ratio is , as compared to K.P.Energy IPO P/E ratio of .
| Ganga Pharmaceuticals IPO | K.P.Energy IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | 91.05 | |
| Promoter Shareholding (Post-Issue) | 68.09 | |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 1.27% |
In the Ganga Pharmaceuticals IPO Retail Individual Investors (RII) are offered 5,12,000 shares while in K.P.Energy IPO retail investors are offered 5,12,000 shares. Qualified Institutional Buyers (QIB) are offered in Ganga Pharmaceuticals IPO and in K.P.Energy IPO.
| Ganga Pharmaceuticals IPO | K.P.Energy IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 0 shares | 48,000 shares |
| QIB | ||
| NII | 5,12,000 shares | 4,36,000 shares |
| RII | 5,12,000 shares | 4,36,000 shares |
| Employee | ||
| Others | ||
| Total | 10,24,000 shares | 8,72,000 shares |
Ganga Pharmaceuticals IPO subscribed in total, whereas K.P.Energy IPO subscribed .
| Ganga Pharmaceuticals IPO | K.P.Energy IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
